We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate; a former F.D.A. commissioner who’s been warning of a pandemic for years; and an economist who thinks Covid-19 may finally change how diseases are ... Show More
Oct 23
692. What Will A.I. Do to (and for) Human Creativity?
Writers, designers, actors, coders, musicians, thinkers — they’re all worried about being replaced by machines. But what if the A.I.s are actually here to help? (Part one of a two-part series.) SOURCES:Sean Astin, actor, president of SAG-AFTRA.Kevin Kelly, co-founder of Wired.Eth ... Show More
59m 9s
Oct 16
691. Is This What a “Good Billionaire” Looks Like?
David Rubenstein, a product of the old bipartisan D.C., made his fortune in private equity. He’s been spending it on “patriotic philanthropy” and institutions like the Kennedy Center, where Trump fired him as chairman. Now he wonders if the center can hold. SOURCES:David Rubenste ... Show More
43m 23s
Nov 2020
S3: The Future after COVID-19
Just before our third season starts we talk with Dr Peter Drobac, a global health physician and Director of the Skoll Centre for Social Entrepreneurship, and Dr Aoife Haney, Research Lecturer in Innovation and Enterprise, about the social, economic and environmental changes that ... Show More
41m 58s